References
- Acuna-Castroviejo D., Martin M., Macias M., Escames G., Leon J., Khaldy H., Reiter R. Melatonin, mitochondria, and cellular bioenergetics. J. Pineal Res. 2001; 30: 65–74
- Arnold S., Goglia F., Kadenbach B. 3,5-Diiodothyronine binds to subunit Va of cytochrole-c oxidase and abolished the allosteric inhibition of respiration by ATP. Eur. J. Biochem. 1998; 252: 325–330
- Betarbet R., Sherer T., MacKenzie G., et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000; 3: 1301–1306
- Betarbet R., Sherer T. B., Greenamyre J. T. Animal models of Parkinson's disease. Bioessays 2002; 24: 308–318
- Blake C., Spitz E., Leehey M., Hoffer B., Boyson S. Platelet mitochondrial respiratory chain function in Parkinson's disease. Mov. Disord. 1997; 12: 3–8
- Dabbeni-Sala F., Di Santo S., Franceschini D., Skaper S., Giusti P. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J. 2001; 15: 164–170
- Greenamyre J., MacKenzie G., Peng T., Stephans S. Mitochondrial dysfunction in Parkinson's disease. Biochem. Soc. Symp. 1999; 66: 85–97
- Heimer G., Bar-Gad I., Goldberg J. A., Bergman H. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-terahydropyridine primate model of Parkinson. J. Neurosci. 2002; 22: 7850–7855
- Jin B. K., Shin D. Y., Jeong M. Y., et al. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats. Neurosci. Lett. 1998; 245: 61–64
- Kirkey K., Johnson C., Rybicki B., Peterson E., Kortsha G., Gorell J. Occupational categories at risk for Parkinson's disease. Am. J. Ind. Med. 2001; 39: 564–571
- Lowry O. H., Resebrough N. J., Farr A. J., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
- Marder K., Logroscino G., Alfaro B., et al. Environmental risk factors for Parkinson's disease in an urban multiethnic community. Neurology 1998; 50: 279–281
- Martin M., Macias M., Escames G., Reiter R., Agapito M. T., Ortiz G. G., Acuna-Castroviejo D. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J. Pineal Res. 2000; 28: 242–248
- Martin M., Macias M., Leon J., Escames G., Khaldy H., Acuna-Castroviejo D. Melatonin increased the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int. J. Biochem. Cell Biol. 2002; 34: 348–357
- Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T., Kagawa Y. Deficiences in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 1989; 163: 1450–1455
- Morin C., Zini R., Simon N., Charbonnier P., Tillement J. P., Le Louet H. Low glucocorticoid concentrations decrease oxidative phosphorylation of isolated rat brain mitochondria: an additional effect of dexamethasone. Fundam. Clin. Pharmacol. 2000; 14: 493–500
- Morin C., Zini R., Simon N., Tillement J. P. Dehydroepiandosterone and alpha-estradiol limit the functional alterations of rat brain mitochondria submitted to different experimental stresses. Neuroscience 2002; 115: 415–424
- Murphy M. P. How understanding the control of energy metabolism can help investigation of mitochondrial dysfunction, regulation and pharmacology. Biochim. Biophys. Acta 2001; 1504: 1–11
- Pinna G., Brödel O., Visser T., Jeitner A., Grau H., Eravci M., Meinhold H., Baumgartner A. Concentrations of seven Iodothyronine metabolites in brain regions and the liver of the adult rat. Endocrinology 2002; 143: 1789–1800
- Rossignol R., Malgat M., Mazat J. P., Letellier T. Threshold effect and tissue specificity. J. Biol. Chem. 1999; 274: 33426–33432
- Rustin P., Chrétien D., Bourgeron T., et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 1994; 228: 35–51
- Simon N., Zini R., Morin C., Bree F., Tillement J. P. Prednisolone and azathioprine worsen the cyclosporine A-induced oxidative phosphorylation decrease of kidney mitochondria. Life Sci. 1997; 61: 659–666
- Simon N., Morin C., Urien S., Tillement J. P., Bruguerolle B. Tacrolimus and Sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria. Br. J. Pharmacol. 2003; 138: 369–376
- Urien S. MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processes. Pharm. Res. 1995; 12: 1225–1230
- Willis G., Armstrong S. A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease. Physiol. Behav. 1999; 66: 785–795